GSK India Sales Growth Falters In Battle With Retailers Over Margins
This article was originally published in PharmAsia News
Executive Summary
A continuing battle between India retailers and drug makers has led to complaints by GlaxoSmithKline and others of boycotts on some of their products that began in mid-September, leading to reduced sales.